Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 September 2022 | Story Andrè Damons | Photo Andrè Damons
Prof Abdon Atangana
Prof Abdon Atangana, Professor of Applied Mathematics in the Institute for Groundwater Studies (IGS) and a highly cited mathematician for the years 2019-2021, says existing mathematical models are used to first fit collected data and then predict future events. It is for this reason he introduced a new concept that can be used to test whether the spread will have one or several waves.

With a new outbreak of the Ebola Virus Disease (EVD) reported this year in Democratic Republic of the Congo (DRC) – the 14th EVD outbreak in the country – researchers at the University of the Free State (UFS) introduced a new concept that can be used to test whether the spread will have one or several waves. They believe the focus should be to identify the source or the hosts of this virus for it to be a complete eradication. 

According to the Centers for Disease Control and Prevention (CDC), the Ministry of Health in the Democratic Republic of the Congo (DRC) declared an outbreak of Ebola in Mbandaka health zone, Equateur Province on April 23, 2022. EVD, formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness affecting humans and other primates. The virus is transmitted to people from wild animals (such as fruit bats, porcupines and non-human primates) and then spreads in the human population through direct contact with the blood, secretions, organs or other bodily fluids of infected people, and with surfaces and materials (e.g. bedding, clothing) contaminated with these fluids, according to the World Health Organisation (WHO).
 
Prof Abdon Atangana, Professor of Applied Mathematics in the Institute for Groundwater Studies (IGS), says existing mathematical models are used to first fit collected data and then predict future events. Predictions help lawmakers to take decisions that will help protect their citizens and their environments. The outbreaks of COVID-19 and other infectious diseases have exposed the weakness of these models as they failed to predict the number of waves and in several instances; they failed to predict accurately day-to-day new infections, daily deaths and recoveries.

Solving the challenges of the current models

In the case of COVID-19 in South Africa, it is predicted that the country had far more infections than what was recorded, which is due to challenges faced by the medical facilities, poverty, inequality, and other factors. With Ebola in the DRC, data recorded are not far from reality due to the nature of the virus and its symptoms. However, the predictions show although some measures have been put in place in DRC and other places where the Ebola virus spread, they will still face some challenges in the future, as the virus will continue to spread but may have less impact. 

“To solve the challenges with the current models, we suggested a new methodology. We suggested that each class should be divided into two subclasses (Detected and undetected) and we also suggested that rates of infection, recovery, death and vaccination classes should be a function of time not constant as suggested previously. These rates are obtained from what we called daily indicator functions. For example, an infection rate should be obtained from recorded data with the addition of an uncertain function that represents non-recorded data (Here more work is still to be done to get a better approximation).

“I introduced a new concept called strength number that can be used to test whether the spread will have one or several waves. The strength number is an accelerative force that helps to provide speed changes, thus if this number is less than zero we have deceleration, meaning there will be a decline in the number of infections. If the number is positive, we have acceleration, meaning we will have an increase in numbers. If the number is zero, the current situation will remain the same,” according to Prof Atangana. 

To provide better prediction, he continues, reliable data are first fitted with the suggested mathematical model. This helps them to know if their mathematical model is replicating the dynamic process of the spread. The next step is to predict future events, to do this, we create three sub-daily indicator functions (minimum, actual, and maximum). These will lead to three systems, the first system represents the worst-case scenario, the second is the actual scenario, and the last is a best-case scenario.

Virus will continue to spread but with less impact

Using this method, Prof Atangana, a highly cited mathematician for the years 2019-2021, says he and Dr Seda Igret Araz, postdoctoral student, were able to predict that, although some measures have been put in place in DRC and other places where the Ebola virus spreads, they will still face some challenges in the future as the virus will continue to spread but may have less impact. 

To properly achieve the conversion from observed facts into mathematical formulations and to address these limitations, he had to ask fundamental questions such as what is the rate of infection, what is the strength of the infection, what are the crossover patterns presented by the spread, how can day-to-day new infected numbers be predicted and what differential operator should be used to model a dynamic process followed by the spread?

This approach was tested for several infectious diseases where we present the case of Ebola in Congo and Covid-19 in South Africa.  

News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors  Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept